Chemours (NYSE:CC) CFO Shane Hostetter Acquires 3,350 Shares of Stock

The Chemours Company (NYSE:CC) CFO Shane Hostetter bought 3,350 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The stock was acquired at an average price of $14.94 per share, with a total value of $50,049.00. Following the completion of the purchase, the chief financial officer directly owned 102,698 shares of the company’s stock, valued at approximately $1,534,308.12. The trade was a 3.37% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Chemours Stock Performance

NYSE CC opened at $14.52 on Tuesday. The business’s 50-day moving average price is $19.08 and its 200 day moving average price is $20.05. The company has a current ratio of 1.66, a quick ratio of 0.88 and a debt-to-equity ratio of 18.98. The Chemours Company has a twelve month low of $10.44 and a twelve month high of $28.67. The company has a market capitalization of $2.19 billion, a PE ratio of -7.60 and a beta of 1.43.

Chemours (NYSE:CC) last posted its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.07). The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Chemours had a negative net margin of 5.00% and a positive return on equity of 60.64%. The firm’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same quarter last year, the firm earned ($2.54) EPS. On average, research analysts predict that The Chemours Company will post 0.91 earnings per share for the current year.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 14th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Friday, August 14th. Chemours’s dividend payout ratio is presently -18.32%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CC. UBS Group reiterated a “neutral” rating and issued a $18.00 target price (down from $29.00) on shares of Chemours in a report on Monday. Morgan Stanley set a $18.00 price objective on Chemours in a research note on Monday. Truist Financial decreased their target price on Chemours from $30.00 to $24.00 and set a “buy” rating for the company in a report on Thursday, August 6th. JPMorgan Chase & Co. increased their target price on shares of Chemours from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, May 21st. Finally, Weiss Ratings lowered shares of Chemours from a “sell (d)” rating to a “sell (d-)” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Chemours has a consensus rating of “Moderate Buy” and an average price target of $21.00.

Institutional Investors Weigh In On Chemours

Several hedge funds have recently modified their holdings of CC. Atlas Capital Advisors Inc. acquired a new position in Chemours during the 4th quarter worth approximately $26,000. Aster Capital Management DIFC Ltd acquired a new stake in Chemours in the fourth quarter valued at approximately $28,000. Covestor Ltd raised its stake in shares of Chemours by 204.7% during the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 1,748 shares during the period. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Chemours during the fourth quarter valued at approximately $31,000. Finally, Rothschild Investment LLC lifted its position in shares of Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares in the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.